Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120062) titled 'Effect of Efsubaglutide Alfa combined with dietary fiber intervention on body weight in overweight/obese patients with polycystic ovary syndrome (PCOS), A multi-center randomized controlled study' on March 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai General Hospital

Condition: Polycystic ovary syndrome, Overweight/obesity

Intervention: Efsubaglutide a group:Efsubaglutide a 3 mg by subcutaneous injection once weekly

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-31

Target Sample Size: Efsubaglutide a group:30;Efsubaglutid...